Jhawat, V., Gupta, S., Agarwal, B. K., Roy, P., & Saini, V. (2019). Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism Is Not Responsible for Antihypertensive Therapy Induced New Onset of Type 2 Diabetes in Essential Hypertension. Clin Med Insights Endocrinol Diabetes.
Citación estilo ChicagoJhawat, Vikas, Sumeet Gupta, Bimal K. Agarwal, Partha Roy, and Vipin Saini. "Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism Is Not Responsible for Antihypertensive Therapy Induced New Onset of Type 2 Diabetes in Essential Hypertension." Clin Med Insights Endocrinol Diabetes 2019.
Cita MLAJhawat, Vikas, et al. "Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism Is Not Responsible for Antihypertensive Therapy Induced New Onset of Type 2 Diabetes in Essential Hypertension." Clin Med Insights Endocrinol Diabetes 2019.